October 3, 2019
A promising cancer drug that's being developed based on a discovery by our Kimberly Kelly, PhD, is attracting major interest -- to the tune of $25 million.
October 26, 2018
The federal Food and Drug Administration has approved a new single-dose drug, baloxavir marboxil, that can shorten the duration of the flu. It’s the first new drug of its type in 20 years.
Our Frederick G. Hayden, MD, and his… Read More
July 8, 2018
Our J. Julius Zhu, PhD, and his colleagues have found a way to create drugs without side effects. Basically, they’ve developed a lab technique that will add a whole new layer of precision to the concept of “precision medicine.”
The… Read More